Consumer directed health plans modelling services

Download How pharmaceutical manufacturers can identify, adapt to and influence trends in Consumer Directed Health Plans (49kb)

Consumer Directed Health Plans (CDHPs) are a new type of health insurance that typically includes high-deductibles, “side accounts” and other benefit design features intended to reduce the cost of medical care while maintaining or improving quality. The authorisation of Health Savings Accounts (HSAs) by Congress in December of 2003 greatly accelerated a trend that began in 2000—some professionalsnow project that CDHPs will grow to 13% of the privately-insured market by 2008. Many pharmaceutical manufacturers have noticed this trend and are taking steps to address it.

PricewaterhouseCoopers’ actuaries, economists, insurance and tax professionals have developed a state-of-the-art process for forecasting the risks and impact of CDHPs on your company. The PricewaterhouseCoopers team will facilitate your selection of initial assumptions based on available economics and actuarial research and then develop forecasts on a product-by-product basis of: revenues from private benefit plans, change in consumers’ out-of-pocket costs and average impact on utilisation. More importantly, our multi-disciplinary team will work closely with your team to assess the strategic implications of the forecasts under alternative sets of assumptions and to identify options for adapting to and influencing CDHP trends.